HSCT is a curative option for many patients (pts) with hematological malignancies.
Significant advances in supportive care and conditioning regimens over the past decade have allowed the extension of this therapy to older individuals.
Information regarding the outcomes of this older subset of pts undergoing HSCT is limited, especially those undergoing haploidential (HI) HSCT.
To describe the outcomes of patients 60 years of age or older undergoing haploidential and matched related (MR) HSCT using the 2-step approach.
Recommended CitationGaballa, MD, Sameh; Alpdogan, MD, Seyfettin Onder; Carabasi, MD, Matthew; Filicko-O'Hara, MD, Joanne; Kasner, MD, Margaret; Leiby, PhD, Benjamin E; Martinez-Outshoorn, MD, Ubaldo E.; Pequignot, MD, Edward C; Rosado, Sarah; Rudolph, MS, Shannon; Wagner, MD, John L; Weiss, MD, Mark; Flomenberg, MD, Neal; and Grosso, DNP, Dolores, "Outcomes of Older Patients Undergoing 2-Step Approach to Haploidentical and Matched Related Peripheral Blood Hematopoietic Stem Cell Transplantation (HSCT): A Single Institutional Experience" (2014). Department of Medical Oncology Faculty Papers. Paper 31.